• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email
    SC 13G/A 1 beauty13ga3-11142024.htm
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C.  20549
    SCHEDULE 13G
    (RULE 13d - 102)
    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
    (Amendment No. 3)*
    The Beauty Health Company
    (Name of Issuer)
    Class A Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
    88331L108
    (CUSIP Number)
    September 30, 2024
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [ ]            Rule 13d-1(b)
    [x]            Rule 13d-1(c)
    [ ]            Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    0
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    0
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    0
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    0%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN




    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners Offshore Master Fund, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    0
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    0
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    0
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    0%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners Offshore, Ltd.
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    0
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    0
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    0
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    0%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    CO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Lugard Road Capital Master Fund, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    LCG Holdings, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    0
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    0
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    0
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    0%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Lugard Road Capital GP, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Group, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Management, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Jonathan Green
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    United States
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    IN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Christian Leone
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    United States
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,095,709
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,095,709
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,095,709
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    IN


    Item 1(a).
    Name of Issuer:
    The Beauty Health Company (“Issuer”)
    Item 1(b).
    Address of Issuer’s Principal Executive Offices:
    2165 Spring Street
    Long Beach, CA 90806

    Item 2.  (a) Name of Persons Filing:
    (b) Address of Principal Business Office or, if None, Residence:
    (c) Citizenship:

    The names and citizenships of the persons filing this statement on Schedule 13G are (collectively, the “Reporting Persons”):

    Luxor Capital Partners, LP (the “Onshore Fund”)
    Citizenship: Delaware

    Luxor Capital Partners Offshore Master Fund, LP (the “Offshore Master Fund”)
    Citizenship: Cayman Islands

    Luxor Capital Partners Offshore, Ltd. (the “Offshore Feeder Fund”)
    Citizenship: Cayman Islands

    Lugard Road Capital Master Fund, LP (the “Lugard Master Fund”)
    Citizenship: Cayman Islands

    LCG Holdings, LLC (“LCG Holdings”)
    Citizenship: Delaware

    Lugard Road Capital GP, LLC (“Lugard GP”)
    Citizenship: Delaware

    Luxor Capital Group, LP (“Luxor Capital Group”)
    Citizenship: Delaware

    Luxor Management, LLC (“Luxor Management”)
    Citizenship: Delaware

    Jonathan Green (“Mr. Green”)
    Citizenship: United States

    Christian Leone (“Mr. Leone”)
    Citizenship: United States


    The principal business address of each of the Onshore Fund, Luxor Capital Group, Luxor Management, Lugard GP, LCG Holdings, Mr. Green and Mr. Leone is 7 Times Square, 43rd Floor, New York, New York 10036.
    The principal business address of each of the Offshore Master Fund, the Offshore Feeder Fund and the Lugard Master Fund is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.
    Item 2(d).
    Title of Class of Securities:
    Class A common stock, par value $0.0001 per share (the “Class A Common Stock”).


    Item 2(e).
    CUSIP Number:
    88331L108

    Item 3.
    If This Statement is Filed Pursuant to Rule 13d 1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
     
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Exchange Act.
     
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Exchange Act.
     
    (c)
    [ ]
    Insurance company defined in Section 3(a)(19) of the Exchange Act.
     
    (d)
    [ ]
    Investment company registered under Section 8 of the Investment Company Act.
     
    (e)
    [ ]
    Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
     
    (f)
    [ ]
    Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
     
    (g)
    [ ]
    Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
     
    (h)
    [ ]
    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
     
    (i)
    [ ]
    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
     
    (j)
    [ ]
    Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
     
    (k)
    [ ]
    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4.
    Ownership.
    (a)
    Amount beneficially owned:
    As of the close of business on September 30, 2024:

    (i)
    The Onshore Fund did not beneficially own any shares of Class A Common Stock;

    (ii)
    The Offshore Master Fund did not beneficially own any shares of Class A Common Stock. The Offshore Feeder Fund, as the owner of a controlling interest in the Offshore Master Fund, did not beneficially own any shares of Common Stock;

    (iii)
    The Lugard Master Fund beneficially owned 1,095,709 shares of Class A Common Stock;

    (vi)
    LCG Holdings, as the general partner of the Onshore Fund and the Offshore Master Fund did not beneficially own any shares of Class A Common Stock;

    (vii)
    Lugard GP, as the general partner of the Lugard Master Fund, may be deemed to have beneficially owned 1,095,709 shares of Class A Common Stock beneficially owned by the Lugard Master Fund;

    (viii)
    Mr. Green, as a managing member of Lugard GP, may be deemed to have beneficially owned 1,095,709 shares of Class A Common Stock beneficially owned by Lugard GP.

    (ix)
    Luxor Capital Group, as the investment manager of the Onshore Fund, the Offshore Feeder Fund and the Offshore Master Fund (collectively, the “Funds”), may be deemed to have beneficially owned 1,095,709 shares of Class A Common Stock beneficially owned by the Funds;

    (x)
    Luxor Management, as the general partner of Luxor Capital Group, may be deemed to have beneficially owned 1,095,709 shares of Class A Common Stock beneficially owned by Luxor Capital Group; and

    (xi)
    Mr. Leone, as the managing member of Luxor Management, may be deemed to have beneficially owned 1,095,709 shares of Class A Common Stock beneficially owned by Luxor Management.


    (b)
    Percent of Class:
    As of the close of business on September 30, 2024, the Reporting Persons may be deemed to have beneficially owned 1,095,709 shares of the Issuer’s Class A Common Stock or less than 1% of the Issuer’s Class A Common Stock outstanding, which percentage was calculated based on 124,020,249 shares of the Issuer’s Class A Common Stock outstanding as of August 6, 2024, as per the information reported in the Issuer’s Form 10-Q filed on August 8, 2024. Specifically, as of the close of business on September 30, 2024 each Reporting Person beneficially owned such percentage as reflected on Item 11 of the applicable Cover Page hereto.
    (c)
    Number of shares as to which such person has:

    (i)
    Sole power to vote or to direct the vote of Class A Common Stock:
    See Cover Pages Items 5-9.

    (ii)
    Shared power to vote or to direct the vote of Class A Common Stock:
    See Cover Pages Items 5-9.

    (iii)
    Sole power to dispose or to direct the disposition of Class A Common Stock:
    See Cover Pages Items 5-9.

    (iv)
    Shared power to dispose or to direct the disposition of Class A Common Stock:
    See Cover Pages Items 5-9.
    Item 5.
    Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x].
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable.
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not applicable.
    Item 8.
    Identification and Classification of Members of the Group.
    See Exhibit A of the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on February 14, 2024.
    Item 9.
    Notice of Dissolution of Group.
    Not applicable.
    Item 10.
    Certification.
    By signing below each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURES
    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
    Dated:  November 14, 2024
    LUXOR CAPITAL PARTNERS, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE MASTER FUND, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE, LTD.
     
       
    By: Luxor Capital Group, LP, as investment manager
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     
     
     
    LUGARD ROAD CAPITAL MASTER FUND, LP
     
       
    By: Lugard Road Capital GP, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL GROUP, LP
     
       
    By: Luxor Management, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LCG HOLDINGS, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUGARD ROAD CAPITAL GP, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR MANAGEMENT, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Jonathan Green
     

       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Christian Leone
     




    Get the next $SKIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    9/19/2025$3.50Buy
    Roth Capital
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on The Beauty Health Company with a new price target

    Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50

    9/19/25 8:39:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

    LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering. HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for

    6/2/26 8:05:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    SEC Filings

    View All

    Amendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - SkinHealth Systems Inc. (0001818093) (Filer)

    5/21/26 4:40:52 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - SkinHealth Systems Inc. (0001818093) (Filer)

    5/12/26 4:08:38 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by SkinHealth Systems Inc.

    10-Q - SkinHealth Systems Inc. (0001818093) (Filer)

    5/7/26 5:16:36 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Beattie Edward Scott

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:24:15 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Shridharani Sachin Mahavir

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:19:24 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Tripp Kenneth Robert

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:15:55 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    View All

    SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

    LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the "Board"): Mr. Kenneth Tripp, Dr. Sachin Shridharani, and Mr. E. Scott Beattie, each effective as of April 17, 2026. "These three appointments reflect exactly the kind of Board we are building at SkinHealth Systems – one that brings extensive operational expertise in medtech, deep clinical authority in aesthetics, and proven leadership in scaling iconic global consumer brands," said Brent Saunders, Chairman of SkinHealth Systems

    4/22/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Financials

    Live finance-specific insights

    View All

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results

    LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 ("Q4 2025"). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold," said Pedro Malha, President and CEO of BeautyHealth. "BeautyHealth enters 2026 with a strong foundation — a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus no

    3/12/26 4:01:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care